Stock DLB DOLBY LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Dolby Laboratories, Inc.

Equities

DLB

US25659T1079

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-18 pm EDT 		5-day change 1st Jan Change
78.29 USD +0.40% Intraday chart for Dolby Laboratories, Inc. -3.96% -9.16%
Mar. 05 Dolby Labs to Seek M&A CI
Mar. 05 Transcript : Dolby Laboratories, Inc. Presents at Morgan Stanley?s Technology, Media & Telecom Conference 2024, Mar-05-2024 08:45 AM

Evolution of the average Target Price on Dolby Laboratories, Inc.

Price target over the last 5 years

History of analyst recommendation changes

37c413.xdI4tpZ4kOiRUxnHmh01XO6cLBIFoUD7DtGmgvXLHs0.i6d-2dgU4Lz1CU6M3m5HC7ixb35V1nKRfpzUu5yxVZ_wvwz1ojfd28Y0IQ~5df284eb4dc5c27b3b8b7f9e02c7e4be

Analyst Recommendations on Dolby Laboratories, Inc.

Rosenblatt Adjusts Price Target on Dolby Laboratories to $98 From $93, Maintains Buy Rating MT
Rosenblatt Adjusts Price Target on Dolby Laboratories to $90 From $85, Maintains Buy Rating MT
Barrington Downgrades Dolby Laboratories to Market Perform From Outperform as Economic Challenges Results in Lower Volumes MT
Barrington Downgrades Dolby Laboratories to Market Perform From Outperform MT
Rosenblatt Adjusts Price Target on Dolby Laboratories to $85 From $90, Maintains Buy Rating MT
Tigress Financial Cuts Dolby Laboratories' Price Target to $116 From $128 'on Near-Term Valuation Rerating;' Buy Rating Kept MT
Rosenblatt Starts Dolby Laboratories at Buy With $90 Price Target MT
Barrington Research Lowers Price Target for Dolby Laboratories to $90 From $115, Maintains Outperform Rating MT
DOLBY LABORATORIES : Barrington Upgrades Dolby Laboratories to Outperform From Market Perform "as New Initiatives Supplement Progress", Sets $115 Price Target MT
DOLBY LABORATORIES : B. Riley Adjusts Dolby Laboratories' Price Target to $89 From $79, Keeps Neutral Rating MT
DOLBY LABORATORIES : Barrington Research Downgrades Dolby Laboratories to Market Perform From Outperform MT
DOLBY LABORATORIES : JP Morgan Adjusts Price Target for Dolby Laboratories to $90 From $78, Maintains Overweight Rating MT
DOLBY LABORATORIES : B. Riley Adjusts Dolby Laboratories' Price Target to $79 from $73, Keeps Neutral Rating MT
DOLBY LABORATORIES : Barrington Research Adjusts PT on Dolby Laboratories to $95 From $83, Citing 'Meaningful Positive Momentum;' Outperform Rating Kept MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
78.29 USD
Average target price
94.95 USD
Spread / Average Target
+21.28%
High Price Target
98 USD
Spread / Highest target
+25.18%
Low Price Target
91.9 USD
Spread / Lowest Target
+17.38%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Dolby Laboratories, Inc.

Rosenblatt Securities
Barrington Research
Tigress Financial
B. Riley

Ratings for Dolby Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. DLB Stock
  4. Consensus Dolby Laboratories, Inc.